HIV treatment support for people with gaps in care
Part of Immune system & allergy, Infections clinical trials.
This study is for people with HIV who have had a gap in care (missed an appointment or had a detectable viral load). It tests a program to help you stay on your dolutegravir-based HIV medication and keep your viral load undetectable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have HIV and are taking a dolutegravir-based medication as your first HIV treatment.
- In the past year, you missed a clinic visit by more than 28 days OR had a viral load of 50 or higher.
- You are willing to keep your contact information updated for the study.
- You do not have active tuberculosis or epilepsy that requires clinic visits, and you are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study offers different types of support to help adults who are starting or restarting HIV treatment. It aims to find which support works best for staying on treatment.
This study tests a support program to help young women stick with their HIV prevention medicine (PrEP). It aims to see if extra support helps them keep taking it regularly.
This study tests a program that helps people with HIV manage depression and stick to their treatment. It's for adults in Cape Town, South Africa, who have a detectable HIV viral load or may have one, and who show signs of depression.
This study is working on a new program to help people living with HIV in Khayelitsha who are struggling with taking their HIV medicine. The program will look at how food insecurity, depression, and trauma can make it harder to stay on treatment, and might help you feel better and stay healthy.
This study is testing a program to help people with HIV stick with their medication. It looks at how well doctors and patients work together to make treatment decisions and improve health outcomes.
This study lets people who finished an earlier HIV treatment study keep getting the same medicine while a new trial is set up. It helps ensure you don't have a gap in your treatment.
Hear when a new Human Immunodeficiency Virus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.